Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon (STAA:NASDAQ)

Core Viewpoint - Yunqi Capital, a 5.1% shareholder of Staar Surgical Company, opposes the proposed sale of the company to Alcon based on the terms announced on August 5 [1] Group 1 - Yunqi Capital believes the sale price of $28 per share is inadequate [1]